highly significantp < 0.001
While this was not observed for stage II and III rectal cancer patients without neoadjuvant therapy, it was highly significant for stage III colon carcinomas ( p < 0.001).
While this was not observed for stage II and III rectal cancer patients without neoadjuvant therapy, it was highly significant for stage III colon carcinomas ( p < 0.001).